Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(0.9)
# 2248
Out of 5,370 analysts
14
Total ratings
66.67%
Success rate
3.11%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ITOS ITeos Therapeutics | Downgrades: Equal-Weight | 13 12 | 10.1 | 18.81% | 6 | May 28, 2025 | |
BCAX Bicara Therapeutics | Upgrades: Equal-Weight | 8 8 | 9.95 | -19.6% | 2 | May 23, 2025 | |
MRUS Merus | Maintains: Overweight | 91 89 | 53.25 | 67.14% | 1 | May 8, 2025 | |
RCUS Arcus Biosciences | Maintains: Overweight | 29 26 | 9.08 | 186.34% | 2 | May 7, 2025 | |
XNCR Xencor | Maintains: Overweight | 37 33 | 9.05 | 264.64% | 2 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 34 | 28.37 | 19.84% | 1 | May 3, 2024 |